IONS – ionis pharmaceuticals, inc. (US:NASDAQ)

News

Ionis Pharmaceuticals (IONS) was given a new $110.00 price target by Canaccord Genuity Group Inc..
How The Ionis Pharmaceuticals (IONS) Story Is Shifting With New Targets And 2026 Catalysts [Yahoo! Finance]
Ionis to hold first quarter 2026 financial results webcast
Ionis Pharmaceuticals (IONS) was given a new $104.00 price target by Raymond James Financial, Inc..
Ionis Pharmaceuticals (IONS) had its price target raised by Bank of America Corporation from $100.00 to $111.00. They now have a "buy" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com